cytarabine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

cytarabine has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alvarez-Leite, JI; Amarante-Mendes, GP; Brumatti, G; Bueno-da-Silva, AE; Rabelo, FL; Ramos, MG	1

Other Studies

1 other study(ies) available for cytarabine and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone

Article	Year
Butyrate increases apoptosis induced by different antineoplastic drugs in monocytic leukemia cells. Chemotherapy, 2004, Volume: 50, Issue:5 Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Blotting, Western; Butyrates; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cytarabine; DNA Replication; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Etoposide; Humans; Leukemia, Monocytic, Acute; Vincristine	2004

Article

Year

Butyrate increases apoptosis induced by different antineoplastic drugs in monocytic leukemia cells.

Chemotherapy, 2004, Volume: 50, Issue:5

Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Blotting, Western; Butyrates; Caspase Inhibitors; Caspases; Cell Line, Tumor; Cytarabine; DNA Replication; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Etoposide; Humans; Leukemia, Monocytic, Acute; Vincristine

2004